ES469353A1 - Un procedimiento para la preparacion de compuestos derivadosde bencimidazol - Google Patents

Un procedimiento para la preparacion de compuestos derivadosde bencimidazol

Info

Publication number
ES469353A1
ES469353A1 ES469353A ES469353A ES469353A1 ES 469353 A1 ES469353 A1 ES 469353A1 ES 469353 A ES469353 A ES 469353A ES 469353 A ES469353 A ES 469353A ES 469353 A1 ES469353 A1 ES 469353A1
Authority
ES
Spain
Prior art keywords
butylamino
alkyl
cycloalkyl
formula
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES469353A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB18438/77A external-priority patent/GB1595316A/en
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES469353A1 publication Critical patent/ES469353A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES469353A 1977-05-03 1978-05-02 Un procedimiento para la preparacion de compuestos derivadosde bencimidazol Expired ES469353A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB18438/77A GB1595316A (en) 1977-05-03 1977-05-03 4-(3-amino-2-hydroxy-propoxy)-benzimidazole derivatives and pharmaceutical compositions containing them
GB4915677 1977-11-25
GB220878 1978-01-19

Publications (1)

Publication Number Publication Date
ES469353A1 true ES469353A1 (es) 1980-01-01

Family

ID=27254036

Family Applications (1)

Application Number Title Priority Date Filing Date
ES469353A Expired ES469353A1 (es) 1977-05-03 1978-05-02 Un procedimiento para la preparacion de compuestos derivadosde bencimidazol

Country Status (18)

Country Link
JP (1) JPS53135979A (de)
AR (2) AR220335A1 (de)
AU (1) AU3569678A (de)
DE (1) DE2819458A1 (de)
DK (1) DK190378A (de)
ES (1) ES469353A1 (de)
FI (1) FI781349A (de)
FR (1) FR2399414A1 (de)
GR (1) GR73669B (de)
IL (1) IL54591A0 (de)
IT (1) IT1096276B (de)
LU (1) LU79591A1 (de)
MC (1) MC1192A1 (de)
NL (1) NL7804794A (de)
NO (1) NO781556L (de)
NZ (1) NZ187066A (de)
PT (1) PT67980A (de)
SE (1) SE7805140L (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2801980A1 (de) 1978-01-18 1979-07-19 Boehringer Mannheim Gmbh 4-hydroxy-2-benzimidazolin-thion- derivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
EP0003758A1 (de) * 1978-02-09 1979-09-05 Ciba-Geigy Ag Verätherte Hydroxy-benzodiheterocyclen und ihre Säureadditionssalze, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE2905877A1 (de) * 1979-02-16 1980-08-28 Boehringer Mannheim Gmbh Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CH661501A5 (fr) * 1982-01-26 1987-07-31 Oreal Composes derivant du amino-3 propanol-2 utilisables pour la teinture des cheveux, leur procede de preparation, composition de teinture les contenant et procede de teinture de cheveux correspondant.
DE3839743A1 (de) * 1988-11-25 1990-05-31 Hoechst Ag Verfahren zur herstellung von benzimidazolonen
WO2014108449A1 (en) 2013-01-08 2014-07-17 Atrogi Ab A screening method, a kit, a method of treatment and a compound for use in a method of treatment
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1058822A (en) * 1963-07-30 1967-02-15 Ici Ltd 3-amino-2-hydroxypropoxy heterocyclic derivatives
CH559729A5 (de) * 1970-10-23 1975-03-14 Hoechst Ag
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
CH624395A5 (de) * 1976-01-08 1981-07-31 Ciba Geigy Ag

Also Published As

Publication number Publication date
AU3569678A (en) 1979-11-08
SE7805140L (sv) 1978-11-04
LU79591A1 (de) 1979-06-13
PT67980B (de) 1980-05-05
IL54591A0 (en) 1978-07-31
JPS53135979A (en) 1978-11-28
FI781349A (fi) 1978-11-04
DK190378A (da) 1978-11-04
FR2399414A1 (fr) 1979-03-02
AR220335A1 (es) 1980-10-31
IT7823000A0 (it) 1978-05-03
NL7804794A (nl) 1978-11-07
GR73669B (de) 1984-03-28
AR219173A1 (es) 1980-07-31
DE2819458A1 (de) 1978-11-16
MC1192A1 (fr) 1979-02-23
PT67980A (en) 1978-06-01
NZ187066A (en) 1981-02-11
IT1096276B (it) 1985-08-26
NO781556L (no) 1978-11-06

Similar Documents

Publication Publication Date Title
ES469353A1 (es) Un procedimiento para la preparacion de compuestos derivadosde bencimidazol
JPS5665880A (en) Morpholine derivative
AU4205000A (en) Xanthine derivatives and analogs as cell signaling inhibitors
MX9800483A (es) Derivados de piperazina y su uso como antagonistas de 5-ht1a.
GB1086192A (en) Phenylcyclopropane derivatives
DE69519385D1 (de) Chinazolinon-arzneimittel sowie deren verwendung
EP0439321A3 (en) Thiazolidine derivatives having anti-hypertensive activity and their therapeutic use
PH30341A (en) Xanthine derivatives for the treatment of secondary nerve cell damage and functional disorders after cranio-cerebral traumas
Szekeres et al. Antiarrhythmic compounds
ES8500884A1 (es) Un procedimiento para la preparacion de nuevos derivados de propanolamina.
US3558777A (en) Pharmacologic processes and compositions containing azaspirodecanediones and azaspiroundecanediones
DK0737475T3 (da) Anvendelse af en muscarin antagonist til fremstilling af et medikament til behandling og regulering af okular udvikling
IE822310L (en) Triazoloquinazolone derivatives
HUT49879A (en) Process for producing new 1',2'-dihydrospiro square brackets open imidazolidine-4,4'(3'h)-quinoline square brackets closed derivatives and pharmaceutical compositions comprising these compounds as active ingredient
UA41329C2 (uk) Фармацевтична композиція для лікування порушень серцевого ритму у великих ссавців та людей, похідні 3-фенілсульфоніл-3,7-діазабіцикло[3,3,1]нонану та лікарський засіб для лікування аритмії
IL101506A0 (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
NZ332484A (en) use of pyridyl and pyrimidyl substituted piperazine derivatives for treating substance abuse disorders
IE810174L (en) Piperazinyl cycloheptatrienones
GR3000930T3 (en) Pyrido (1,2-a) pyrimidine derivatives
EP0274230A3 (en) Use of 2-oxo-imidazolidine derivatives in the prophylaxis and treatment of heart failure
ES8203380A1 (es) Un procedimiento de preparacion de 4-(1-piperazinil)-fu- ro(3,2-c)piridinas
GB1531091A (en) Pharmaceutical combination preparations
EP0272849A3 (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases